Aptose Biosciences Inc (APTO)

Aptose Biosciences Inc Azioni (APTO) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	3.82% 12.13	11.68	14.45	14.10	10.40
Nonoperating Income/Loss	26.50% 0.172	0.234	0.323	0.42	0.403
Income/Loss From Continuing Operations Before Tax	4.44% -11.96	-11.45	-14.13	-13.68	-10.00
Income/Loss From Continuing Operations After Tax	4.44% -11.96	-11.45	-14.13	-13.68	-10.00
Net Income/Loss	4.44% -11.96	-11.45	-14.13	-13.68	-10.00
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	94.40% 0.364	6.495	6.234	92.56	-92.16
Diluted Average Shares	94.40% 0.364	6.495	6.234	92.56	-
Basic Earnings Per Share	10.80% -1.57	-1.76	-2.27	-2.25	-0.11
Diluted Earnings Per Share	10.80% -1.57	-1.76	-2.27	-2.25	-0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-